跳至主要内容
临床试验/NL-OMON55167
NL-OMON55167已完成不适用

Scope change in vasculitis: the role of monocytes and macrophages in ANCA-associated glomerulonephritis - MOMA study

Academisch Medisch Centrum0 个研究点目标入组 103 人开始时间: 待定最近更新:

试验速览

阶段
不适用
状态
已完成
入组人数
103

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 64(—)

入选标准

  • In order to be eligible to participate in this study, a subject must meet
  • following general and group-specific criteria:
  • 1. Age: 18 years and older
  • Group-specific
  • Patients with ANCA-associated glomerulonephritis (AGN)
  • 1. Diagnosed with granulomatosis with polyangiitis (GPA) or microscopic
  • polyangiitis (MPA)
  • 2. Renal involvement attributable to vasculitis
  • 3. History of PR3/MPO positivity as determined by ELISA in the context of
  • routine clinical care.
  • Hemodialysis controls
  • 1. End stage kidney failure (ESRD) requiring hemodialysis
  • Active infection controls
  • 1. Clinical diagnosis: pneumonia (CURB-65 score 2-5, imaging: X-thorax or
  • CT-thorax showing infiltrates) or complicated urine tract infection
  • 2. Admitted to the hospital <48h
  • Nephrectomy controls
  • 1. Patients who undergo a (partial) nephrectomy for treatment of a renal cell
  • carcinoma, who give consent for the use of surplus kidney tissue for research
  • Patients with (suspected) ANCA vasculitis with pulmonary involvement (API)
  • 1. Suspected or diagnosed with ANCA-associated vasculitis
  • 2. (Suspected) pulmonary involvement attributable to vasculitis
  • 3. Patients who undergo a bronchoalveolar lavage (BAL) for diagnostic purposes
  • SLE patients with renal involvement
  • 1. SLE diagnosis according to the 2019 EULAR/ACR Classification Criteria18
  • 2. Renal involvement attributable to SLE
  • 3. History of ANA positivity

排除标准

  • Patients with ANCA-associated glomerulonephritis (AGN) and Patients with
  • (suspected) ANCA vasculitis with pulmonary involvement
  • 1. A history of drug-induced ANCA-associated vasculitis
  • 2. Active infection as shown by microbiological analysis
  • Healthy controls and hemodialysis controls
  • 1. Active infection as shown by microbiological analysis
  • 2. A history of any auto-immune disease
  • 3. Use of immunosuppressive medication
  • Infection controls
  • 1. Other infection than pneumonia/urine tract infection
  • 2. A history of any auto-immune disease
  • 3. Use of immunosuppressive medication
  • SLE patients
  • 1. A history of drug-induced SLE
  • 2. Active infection as shown by microbiological analysis

研究者

相似试验